MC
ABBV icon

Mathes Company’s AbbVie ABBV Stock Holding History

Mathes Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Hold
1,000
– – 0.08% 114
2026
Q1 		$217K Hold
1,000
– – 0.08% 119
2025
Q4 		$228K Hold
1,000
– – 0.08% 118
2025
Q3 		$232K Buy
+1,000
New +$204K 0.08% 119
2024
Q2 		– Sell
-1,311
Closed -$239K – 129
2024
Q1 		$239K Hold
1,311
– – 0.09% 124
2023
Q4 		$203K Buy
+1,311
New +$191K 0.08% 127
2022
Q4 		$226K Buy
+1,400
New +$215K 0.11% 116
2022
Q3 		– Sell
-1,400
Closed -$214K – 126
2022
Q2 		$214K Hold
1,400
– – 0.1% 119
2022
Q1 		$227K Buy
+1,400
New +$203K 0.09% 124
2015
Q3 		– Sell
-3,495
Closed -$235K – 127
2015
Q2 		$235K Buy
+3,495
New +$228K 0.13% 137

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mathes Company's ABBV Position: Q2 2026 in Review

Mathes Company held its AbbVie (ABBV) position steady in Q2 2026 at 1,000 shares worth $251K. The position accounts for 0.08% of the portfolio, ranked #114.

Mathes Company first reported a position in ABBV in Q2 2015 and has held it in 10 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mathes Company held 1,000 shares of AbbVie worth $251K as of Q2 2026.
  • Mathes Company left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.08% of Mathes Company's portfolio in Q2 2026, its #114 holding.
  • Mathes Company first reported a position in AbbVie in Q2 2015 and has held it in 10 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.